Finasteride Market Report

Global Finasteride Market Study Report 2022 Historical Trends, Growth, and Forecast to 2028

  • POSTDATE：Mar 06, 2022
  • PAGES：141
  • REPORT CODE：GMM798021
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Finasteride market report explains the definition, types, applications, major countries, and major players of the Finasteride market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.

    The report contains qualitative and quantitative analysis of the entire industry.

    The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.

    By Player:

    • Teva Pharmaceuticals

    • Shandong Renhetang Pharmaceutical

    • Henan Topfond

    • Zhejiang CONBA Pharmaceutical

    • Sandoz

    • Accord Pharmaceuticals

    • Cipla

    • Actavis

    • RelonChem

    • Guangdong Eashu Pharmacetical

    • Merck

    By Type:

    • 1 mg Tablet

    • 5 mg Tablet

    By End-User:

    • Medical Uses

    • Prostate Enlargement

    • Prostate Cancer

    • Scalp Hair Loss

    • Excessive Hair Growth

    • Transgender Women

    By Region:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • Spain

    • France

    • Italy

    • Denmark

    • Finland

    • Norway

    • Sweden

    • Poland

    • Russia

    • Turkey

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Pakistan

    • Bangladesh

    • Indonesia

    • Thailand

    • Singapore

    • Malaysia

    • Philippines

    • Vietnam

    • Others

    South America

    • Brazil

    • Colombia

    • Chile

    • Argentina

    • Venezuela

    • Peru

    • Puerto Rico

    • Ecuador

    • Others

    GCC

    • Bahrain

    • Kuwait

    • Oman

    • Qatar

    • Saudi Arabia

    • United Arab Emirates

    Africa

    • Nigeria

    • South Africa

    • Egypt

    • Algeriat

    • Others

    Oceania

    • Australia

    • New Zealand

  • TABLE OF CONTENT

    1. Global Finasteride Executive Summary

    • 1.1 Introduction

    • 1.2 Market Panorama, 2022

    2 Coronavirus Impact

    • 2.1 Finasteride Outlook to 2028- Original Forecasts

    • 2.2 Finasteride Outlook to 2028- COVID-19 Affected Forecasts

    • 2.3 Impact on Industry

    3 Strategic Analytics to Boost Productivity and Profitability

    • 3.1 Potential Market Drivers and Opportunities

    • 3.2 New Challenges and Strategies

    • 3.3 Short Term and Long Term Finasteride Market Trends

    4 Key Inferences

    5 Market Overview

    • 5.1 Current Market Scenario

    • 5.2 Porter's Five Forces Analysis

      • 5.2.1 Bargaining Power of Suppliers

      • 5.2.2 Bargaining Power of Consumers

      • 5.2.3 Threat of New Entrants

      • 5.2.4 Threat of Substitute Product and Services

      • 5.2.5 Competitive Rivalry within the Industry

    6 Global Finasteride Market- Recent Developments

    • 6.1 Finasteride Market News and Developments

    • 6.2 Finasteride Market Deals Landscape

    7 Finasteride Raw Materials and Cost Structure Analysis

    • 7.1 Finasteride Key Raw Materials

    • 7.2 Finasteride Price Trend of Key Raw Materials

    • 7.3 Finasteride Key Suppliers of Raw Materials

    • 7.4 Finasteride Market Concentration Rate of Raw Materials

    • 7.5 Finasteride Cost Structure Analysis

      • 7.5.1 Finasteride Raw Materials Analysis

      • 7.5.2 Finasteride Labor Cost Analysis

      • 7.5.3 Finasteride Manufacturing Expenses Analysis

    8 Global Finasteride Import and Export Analysis (Top 10 Countries)

    • 8.1 Global Finasteride Import by Region (Top 10 Countries) (2017-2028)

    • 8.2 Global Finasteride Export by Region (Top 10 Countries) (2017-2028)

    9 Global Finasteride Market Outlook by Types and Applications to 2022

    • 9.1 Global Finasteride Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global 1 mg Tablet Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global 5 mg Tablet Consumption and Growth Rate (2017-2022)

    • 9.2 Global Finasteride Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Medical Uses Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Prostate Enlargement Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Prostate Cancer Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Scalp Hair Loss Consumption and Growth Rate (2017-2022)

      • 9.2.5 Global Excessive Hair Growth Consumption and Growth Rate (2017-2022)

      • 9.2.6 Global Transgender Women Consumption and Growth Rate (2017-2022)

    10 Region and Country-wise Finasteride Market Analysis and Outlook till 2022

    • 10.1 Global Finasteride Consumption (2017-2022)

    • 10.2 North America Consumption Analysis

      • 10.2.1 United States Finasteride Consumption (2017-2022)

      • 10.2.2 Canada Finasteride Consumption (2017-2022)

      • 10.2.3 Mexico Finasteride Consumption (2017-2022)

    • 10.3 Europe Consumption Analysis

      • 10.3.1 Germany Finasteride Consumption (2017-2022)

      • 10.3.2 UK Finasteride Consumption (2017-2022)

      • 10.3.3 Spain Finasteride Consumption (2017-2022)

      • 10.3.4 Belgium Finasteride Consumption (2017-2022)

      • 10.3.5 France Finasteride Consumption (2017-2022)

      • 10.3.6 Italy Finasteride Consumption (2017-2022)

      • 10.3.7 Denmark Finasteride Consumption (2017-2022)

      • 10.3.8 Finland Finasteride Consumption (2017-2022)

      • 10.3.9 Norway Finasteride Consumption (2017-2022)

      • 10.3.10 Sweden Finasteride Consumption (2017-2022)

      • 10.3.11 Poland Finasteride Consumption (2017-2022)

      • 10.3.12 Russia Finasteride Consumption (2017-2022)

      • 10.3.13 Turkey Finasteride Consumption (2017-2022)

    • 10.4 APAC Consumption Analysis

      • 10.4.1 China Finasteride Consumption (2017-2022)

      • 10.4.2 Japan Finasteride Consumption (2017-2022)

      • 10.4.3 India Finasteride Consumption (2017-2022)

      • 10.4.4 South Korea Finasteride Consumption (2017-2022)

      • 10.4.5 Pakistan Finasteride Consumption (2017-2022)

      • 10.4.6 Bangladesh Finasteride Consumption (2017-2022)

      • 10.4.7 Indonesia Finasteride Consumption (2017-2022)

      • 10.4.8 Thailand Finasteride Consumption (2017-2022)

      • 10.4.9 Singapore Finasteride Consumption (2017-2022)

      • 10.4.10 Malaysia Finasteride Consumption (2017-2022)

      • 10.4.11 Philippines Finasteride Consumption (2017-2022)

      • 10.4.12 Vietnam Finasteride Consumption (2017-2022)

    • 10.5 South America Consumption Analysis

      • 10.5.1 Brazil Finasteride Consumption (2017-2022)

      • 10.5.2 Colombia Finasteride Consumption (2017-2022)

      • 10.5.3 Chile Finasteride Consumption (2017-2022)

      • 10.5.4 Argentina Finasteride Consumption (2017-2022)

      • 10.5.5 Venezuela Finasteride Consumption (2017-2022)

      • 10.5.6 Peru Finasteride Consumption (2017-2022)

      • 10.5.7 Puerto Rico Finasteride Consumption (2017-2022)

      • 10.5.8 Ecuador Finasteride Consumption (2017-2022)

    • 10.6 GCC Consumption Analysis

      • 10.6.1 Bahrain Finasteride Consumption (2017-2022)

      • 10.6.2 Kuwait Finasteride Consumption (2017-2022)

      • 10.6.3 Oman Finasteride Consumption (2017-2022)

      • 10.6.4 Qatar Finasteride Consumption (2017-2022)

      • 10.6.5 Saudi Arabia Finasteride Consumption (2017-2022)

      • 10.6.6 United Arab Emirates Finasteride Consumption (2017-2022)

    • 10.7 Africa Consumption Analysis

      • 10.7.1 Nigeria Finasteride Consumption (2017-2022)

      • 10.7.2 South Africa Finasteride Consumption (2017-2022)

      • 10.7.3 Egypt Finasteride Consumption (2017-2022)

      • 10.7.4 Algeria Finasteride Consumption (2017-2022)

    • 10.8 Oceania Consumption Analysis

      • 10.8.1 Australia Finasteride Consumption (2017-2022)

      • 10.8.2 New Zealand Finasteride Consumption (2017-2022)

    11 Global Finasteride Competitive Analysis

    • 11.1 Teva Pharmaceuticals

      • 11.1.1 Teva Pharmaceuticals Company Details

      • 11.1.2 Teva Pharmaceuticals Finasteride Sales, Price, Value and Gross Profit (2017-2022)

      • 11.1.3 Teva Pharmaceuticals Finasteride Main Business and Markets Served

      • 11.1.4 Teva Pharmaceuticals Finasteride Product Portfolio

      • 11.1.5 Recent Research and Development Strategies

    • 11.2 Shandong Renhetang Pharmaceutical

      • 11.2.1 Shandong Renhetang Pharmaceutical Company Details

      • 11.2.2 Shandong Renhetang Pharmaceutical Finasteride Sales, Price, Value and Gross Profit (2017-2022)

      • 11.2.3 Shandong Renhetang Pharmaceutical Finasteride Main Business and Markets Served

      • 11.2.4 Shandong Renhetang Pharmaceutical Finasteride Product Portfolio

      • 11.2.5 Recent Research and Development Strategies

    • 11.3 Henan Topfond

      • 11.3.1 Henan Topfond Company Details

      • 11.3.2 Henan Topfond Finasteride Sales, Price, Value and Gross Profit (2017-2022)

      • 11.3.3 Henan Topfond Finasteride Main Business and Markets Served

      • 11.3.4 Henan Topfond Finasteride Product Portfolio

      • 11.3.5 Recent Research and Development Strategies

    • 11.4 Zhejiang CONBA Pharmaceutical

      • 11.4.1 Zhejiang CONBA Pharmaceutical Company Details

      • 11.4.2 Zhejiang CONBA Pharmaceutical Finasteride Sales, Price, Value and Gross Profit (2017-2022)

      • 11.4.3 Zhejiang CONBA Pharmaceutical Finasteride Main Business and Markets Served

      • 11.4.4 Zhejiang CONBA Pharmaceutical Finasteride Product Portfolio

      • 11.4.5 Recent Research and Development Strategies

    • 11.5 Sandoz

      • 11.5.1 Sandoz Company Details

      • 11.5.2 Sandoz Finasteride Sales, Price, Value and Gross Profit (2017-2022)

      • 11.5.3 Sandoz Finasteride Main Business and Markets Served

      • 11.5.4 Sandoz Finasteride Product Portfolio

      • 11.5.5 Recent Research and Development Strategies

    • 11.6 Accord Pharmaceuticals

      • 11.6.1 Accord Pharmaceuticals Company Details

      • 11.6.2 Accord Pharmaceuticals Finasteride Sales, Price, Value and Gross Profit (2017-2022)

      • 11.6.3 Accord Pharmaceuticals Finasteride Main Business and Markets Served

      • 11.6.4 Accord Pharmaceuticals Finasteride Product Portfolio

      • 11.6.5 Recent Research and Development Strategies

    • 11.7 Cipla

      • 11.7.1 Cipla Company Details

      • 11.7.2 Cipla Finasteride Sales, Price, Value and Gross Profit (2017-2022)

      • 11.7.3 Cipla Finasteride Main Business and Markets Served

      • 11.7.4 Cipla Finasteride Product Portfolio

      • 11.7.5 Recent Research and Development Strategies

    • 11.8 Actavis

      • 11.8.1 Actavis Company Details

      • 11.8.2 Actavis Finasteride Sales, Price, Value and Gross Profit (2017-2022)

      • 11.8.3 Actavis Finasteride Main Business and Markets Served

      • 11.8.4 Actavis Finasteride Product Portfolio

      • 11.8.5 Recent Research and Development Strategies

    • 11.9 RelonChem

      • 11.9.1 RelonChem Company Details

      • 11.9.2 RelonChem Finasteride Sales, Price, Value and Gross Profit (2017-2022)

      • 11.9.3 RelonChem Finasteride Main Business and Markets Served

      • 11.9.4 RelonChem Finasteride Product Portfolio

      • 11.9.5 Recent Research and Development Strategies

    • 11.10 Guangdong Eashu Pharmacetical

      • 11.10.1 Guangdong Eashu Pharmacetical Company Details

      • 11.10.2 Guangdong Eashu Pharmacetical Finasteride Sales, Price, Value and Gross Profit (2017-2022)

      • 11.10.3 Guangdong Eashu Pharmacetical Finasteride Main Business and Markets Served

      • 11.10.4 Guangdong Eashu Pharmacetical Finasteride Product Portfolio

      • 11.10.5 Recent Research and Development Strategies

    • 11.11 Merck

      • 11.11.1 Merck Company Details

      • 11.11.2 Merck Finasteride Sales, Price, Value and Gross Profit (2017-2022)

      • 11.11.3 Merck Finasteride Main Business and Markets Served

      • 11.11.4 Merck Finasteride Product Portfolio

      • 11.11.5 Recent Research and Development Strategies

    12 Global Finasteride Market Outlook by Types and Applications to 2028

    • 12.1 Global Finasteride Consumption Forecast and Growth Rate by Type (2022-2028)

      • 12.1.1 Global 1 mg Tablet Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.2 Global 5 mg Tablet Consumption Forecast and Growth Rate (2022-2028)

    • 12.2 Global Finasteride Consumption Forecast and Growth Rate by Application (2022-2028)

      • 12.2.1 Global Medical Uses Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.2 Global Prostate Enlargement Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.3 Global Prostate Cancer Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.4 Global Scalp Hair Loss Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.5 Global Excessive Hair Growth Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.6 Global Transgender Women Consumption Forecast and Growth Rate (2022-2028)

    13 Country-wise Finasteride Market Analysis and Outlook to 2028

    • 13.1 Global Finasteride Consumption Forecast (2022-2028)

    • 13.2 North America Consumption Analysis

      • 13.2.1 United States Finasteride Consumption Forecast (2022-2028)

      • 13.2.2 Canada Finasteride Consumption Forecast (2022-2028)

      • 13.2.3 Mexico Finasteride Consumption Forecast (2022-2028)

    • 13.3 Europe Consumption Analysis

      • 13.3.1 Germany Finasteride Consumption Forecast (2022-2028)

      • 13.3.2 UK Finasteride Consumption Forecast (2022-2028)

      • 13.3.3 Spain Finasteride Consumption Forecast (2022-2028)

      • 13.3.4 Belgium Finasteride Consumption Forecast (2022-2028)

      • 13.3.5 France Finasteride Consumption Forecast (2022-2028)

      • 13.3.6 Italy Finasteride Consumption Forecast (2022-2028)

      • 13.3.7 Denmark Finasteride Consumption Forecast (2022-2028)

      • 13.3.8 Finland Finasteride Consumption Forecast (2022-2028)

      • 13.3.9 Norway Finasteride Consumption Forecast (2022-2028)

      • 13.3.10 Sweden Finasteride Consumption Forecast (2022-2028)

      • 13.3.11 Poland Finasteride Consumption Forecast (2022-2028)

      • 13.3.12 Russia Finasteride Consumption Forecast (2022-2028)

      • 13.3.13 Turkey Finasteride Consumption Forecast (2022-2028)

    • 13.4 APAC Consumption Analysis

      • 13.4.1 China Finasteride Consumption Forecast (2022-2028)

      • 13.4.2 Japan Finasteride Consumption Forecast (2022-2028)

      • 13.4.3 India Finasteride Consumption Forecast (2022-2028)

      • 13.4.4 South Korea Finasteride Consumption Forecast (2022-2028)

      • 13.4.5 Pakistan Finasteride Consumption Forecast (2022-2028)

      • 13.4.6 Bangladesh Finasteride Consumption Forecast (2022-2028)

      • 13.4.7 Indonesia Finasteride Consumption Forecast (2022-2028)

      • 13.4.8 Thailand Finasteride Consumption Forecast (2022-2028)

      • 13.4.9 Singapore Finasteride Consumption Forecast (2022-2028)

      • 13.4.10 Malaysia Finasteride Consumption Forecast (2022-2028)

      • 13.4.11 Philippines Finasteride Consumption Forecast (2022-2028)

      • 13.4.12 Vietnam Finasteride Consumption Forecast (2022-2028)

    • 13.5 South America Consumption Analysis

      • 13.5.1 Brazil Finasteride Consumption Forecast (2022-2028)

      • 13.5.2 Colombia Finasteride Consumption Forecast (2022-2028)

      • 13.5.3 Chile Finasteride Consumption Forecast (2022-2028)

      • 13.5.4 Argentina Finasteride Consumption Forecast (2022-2028)

      • 13.5.5 Venezuela Finasteride Consumption Forecast (2022-2028)

      • 13.5.6 Peru Finasteride Consumption Forecast (2022-2028)

      • 13.5.7 Puerto Rico Finasteride Consumption Forecast (2022-2028)

      • 13.5.8 Ecuador Finasteride Consumption Forecast (2022-2028)

    • 13.6 GCC Consumption Analysis

      • 13.6.1 Bahrain Finasteride Consumption Forecast (2022-2028)

      • 13.6.2 Kuwait Finasteride Consumption Forecast (2022-2028)

      • 13.6.3 Oman Finasteride Consumption Forecast (2022-2028)

      • 13.6.4 Qatar Finasteride Consumption Forecast (2022-2028)

      • 13.6.5 Saudi Arabia Finasteride Consumption Forecast (2022-2028)

      • 13.6.6 United Arab Emirates Finasteride Consumption Forecast (2022-2028)

    • 13.7 Africa Consumption Analysis

      • 13.7.1 Nigeria Finasteride Consumption Forecast (2022-2028)

      • 13.7.2 South Africa Finasteride Consumption Forecast (2022-2028)

      • 13.7.3 Egypt Finasteride Consumption Forecast (2022-2028)

      • 13.7.4 Algeria Finasteride Consumption Forecast (2022-2028)

    • 13.8 Oceania Consumption Analysis

      • 13.8.1 Australia Finasteride Consumption Forecast (2022-2028)

      • 13.8.2 New Zealand Finasteride Consumption Forecast (2022-2028)

    14 Conclusions


    The List of Tables and Figures

    • Table Definition of Finasteride

    • Figure of Finasteride Picture

    • Table Global Finasteride Import by Region (Top 10 Countries) (2017-2028)

    • Table Global Finasteride Export by Region (Top 10 Countries) (2017-2028)

    • Figure Global 1 mg Tablet Consumption and Growth Rate (2017-2022)

    • Figure Global 5 mg Tablet Consumption and Growth Rate (2017-2022)

    • Figure Global Medical Uses Consumption and Growth Rate (2017-2022)

    • Figure Global Prostate Enlargement Consumption and Growth Rate (2017-2022)

    • Figure Global Prostate Cancer Consumption and Growth Rate (2017-2022)

    • Figure Global Scalp Hair Loss Consumption and Growth Rate (2017-2022)

    • Figure Global Excessive Hair Growth Consumption and Growth Rate (2017-2022)

    • Figure Global Transgender Women Consumption and Growth Rate (2017-2022)

    • Figure Global Finasteride Consumption by Country (2017-2022)

    • Table North America Finasteride Consumption by Country (2017-2022)

    • Figure United States Finasteride Consumption and Growth Rate (2017-2022)

    • Figure Canada Finasteride Consumption and Growth Rate (2017-2022)

    • Figure Mexico Finasteride Consumption and Growth Rate (2017-2022)

    • Table Europe Finasteride Consumption by Country (2017-2022)

    • Figure Germany Finasteride Consumption and Growth Rate (2017-2022)

    • Figure UK Finasteride Consumption and Growth Rate (2017-2022)

    • Figure Spain Finasteride Consumption and Growth Rate (2017-2022)

    • Figure Belgium Finasteride Consumption and Growth Rate (2017-2022)

    • Figure France Finasteride Consumption and Growth Rate (2017-2022)

    • Figure Italy Finasteride Consumption and Growth Rate (2017-2022)

    • Figure Denmark Finasteride Consumption and Growth Rate (2017-2022)

    • Figure Finland Finasteride Consumption and Growth Rate (2017-2022)

    • Figure Norway Finasteride Consumption and Growth Rate (2017-2022)

    • Figure Sweden Finasteride Consumption and Growth Rate (2017-2022)

    • Figure Poland Finasteride Consumption and Growth Rate (2017-2022)

    • Figure Russia Finasteride Consumption and Growth Rate (2017-2022)

    • Figure Turkey Finasteride Consumption and Growth Rate (2017-2022)

    • Table APAC Finasteride Consumption by Country (2017-2022)

    • Figure China Finasteride Consumption and Growth Rate (2017-2022)

    • Figure Japan Finasteride Consumption and Growth Rate (2017-2022)

    • Figure India Finasteride Consumption and Growth Rate (2017-2022)

    • Figure South Korea Finasteride Consumption and Growth Rate (2017-2022)

    • Figure Pakistan Finasteride Consumption and Growth Rate (2017-2022)

    • Figure Bangladesh Finasteride Consumption and Growth Rate (2017-2022)

    • Figure Indonesia Finasteride Consumption and Growth Rate (2017-2022)

    • Figure Thailand Finasteride Consumption and Growth Rate (2017-2022)

    • Figure Singapore Finasteride Consumption and Growth Rate (2017-2022)

    • Figure Malaysia Finasteride Consumption and Growth Rate (2017-2022)

    • Figure Philippines Finasteride Consumption and Growth Rate (2017-2022)

    • Figure Vietnam Finasteride Consumption and Growth Rate (2017-2022)

    • Table South America Finasteride Consumption by Country (2017-2022)

    • Figure Brazil Finasteride Consumption and Growth Rate (2017-2022)

    • Figure Colombia Finasteride Consumption and Growth Rate (2017-2022)

    • Figure Chile Finasteride Consumption and Growth Rate (2017-2022)

    • Figure Argentina Finasteride Consumption and Growth Rate (2017-2022)

    • Figure Venezuela Finasteride Consumption and Growth Rate (2017-2022)

    • Figure Peru Finasteride Consumption and Growth Rate (2017-2022)

    • Figure Puerto Rico Finasteride Consumption and Growth Rate (2017-2022)

    • Figure Ecuador Finasteride Consumption and Growth Rate (2017-2022)

    • Table GCC Finasteride Consumption by Country (2017-2022)

    • Figure Bahrain Finasteride Consumption and Growth Rate (2017-2022)

    • Figure Kuwait Finasteride Consumption and Growth Rate (2017-2022)

    • Figure Oman Finasteride Consumption and Growth Rate (2017-2022)

    • Figure Qatar Finasteride Consumption and Growth Rate (2017-2022)

    • Figure Saudi Arabia Finasteride Consumption and Growth Rate (2017-2022)

    • Figure United Arab Emirates Finasteride Consumption and Growth Rate (2017-2022)

    • Table Africa Finasteride Consumption by Country (2017-2022)

    • Figure Nigeria Finasteride Consumption and Growth Rate (2017-2022)

    • Figure South Africa Finasteride Consumption and Growth Rate (2017-2022)

    • Figure Egypt Finasteride Consumption and Growth Rate (2017-2022)

    • Figure Algeria Finasteride Consumption and Growth Rate (2017-2022)

    • Table Oceania Finasteride Consumption by Country (2017-2022)

    • Figure Australia Finasteride Consumption and Growth Rate (2017-2022)

    • Figure New Zealand Finasteride Consumption and Growth Rate (2017-2022)

    • Table Teva Pharmaceuticals Company Details

    • Table Teva Pharmaceuticals Finasteride Sales, Price, Value and Gross Profit (2017-2022)

    • Table Teva Pharmaceuticals Finasteride Main Business and Markets Served

    • Table Teva Pharmaceuticals Finasteride Product Portfolio

    • Table Shandong Renhetang Pharmaceutical Company Details

    • Table Shandong Renhetang Pharmaceutical Finasteride Sales, Price, Value and Gross Profit (2017-2022)

    • Table Shandong Renhetang Pharmaceutical Finasteride Main Business and Markets Served

    • Table Shandong Renhetang Pharmaceutical Finasteride Product Portfolio

    • Table Henan Topfond Company Details

    • Table Henan Topfond Finasteride Sales, Price, Value and Gross Profit (2017-2022)

    • Table Henan Topfond Finasteride Main Business and Markets Served

    • Table Henan Topfond Finasteride Product Portfolio

    • Table Zhejiang CONBA Pharmaceutical Company Details

    • Table Zhejiang CONBA Pharmaceutical Finasteride Sales, Price, Value and Gross Profit (2017-2022)

    • Table Zhejiang CONBA Pharmaceutical Finasteride Main Business and Markets Served

    • Table Zhejiang CONBA Pharmaceutical Finasteride Product Portfolio

    • Table Sandoz Company Details

    • Table Sandoz Finasteride Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sandoz Finasteride Main Business and Markets Served

    • Table Sandoz Finasteride Product Portfolio

    • Table Accord Pharmaceuticals Company Details

    • Table Accord Pharmaceuticals Finasteride Sales, Price, Value and Gross Profit (2017-2022)

    • Table Accord Pharmaceuticals Finasteride Main Business and Markets Served

    • Table Accord Pharmaceuticals Finasteride Product Portfolio

    • Table Cipla Company Details

    • Table Cipla Finasteride Sales, Price, Value and Gross Profit (2017-2022)

    • Table Cipla Finasteride Main Business and Markets Served

    • Table Cipla Finasteride Product Portfolio

    • Table Actavis Company Details

    • Table Actavis Finasteride Sales, Price, Value and Gross Profit (2017-2022)

    • Table Actavis Finasteride Main Business and Markets Served

    • Table Actavis Finasteride Product Portfolio

    • Table RelonChem Company Details

    • Table RelonChem Finasteride Sales, Price, Value and Gross Profit (2017-2022)

    • Table RelonChem Finasteride Main Business and Markets Served

    • Table RelonChem Finasteride Product Portfolio

    • Table Guangdong Eashu Pharmacetical Company Details

    • Table Guangdong Eashu Pharmacetical Finasteride Sales, Price, Value and Gross Profit (2017-2022)

    • Table Guangdong Eashu Pharmacetical Finasteride Main Business and Markets Served

    • Table Guangdong Eashu Pharmacetical Finasteride Product Portfolio

    • Table Merck Company Details

    • Table Merck Finasteride Sales, Price, Value and Gross Profit (2017-2022)

    • Table Merck Finasteride Main Business and Markets Served

    • Table Merck Finasteride Product Portfolio

    • Figure Global 1 mg Tablet Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global 5 mg Tablet Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Medical Uses Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Prostate Enlargement Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Prostate Cancer Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Scalp Hair Loss Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Excessive Hair Growth Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Transgender Women Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Finasteride Consumption Forecast by Country (2022-2028)

    • Table North America Finasteride Consumption Forecast by Country (2022-2028)

    • Figure United States Finasteride Consumption Forecast and Growth Rate (2022-2028)

    • Figure Canada Finasteride Consumption Forecast and Growth Rate (2022-2028)

    • Figure Mexico Finasteride Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Finasteride Consumption Forecast by Country (2022-2028)

    • Figure Germany Finasteride Consumption Forecast and Growth Rate (2022-2028)

    • Figure UK Finasteride Consumption Forecast and Growth Rate (2022-2028)

    • Figure Spain Finasteride Consumption Forecast and Growth Rate (2022-2028)

    • Figure Belgium Finasteride Consumption Forecast and Growth Rate (2022-2028)

    • Figure France Finasteride Consumption Forecast and Growth Rate (2022-2028)

    • Figure Italy Finasteride Consumption Forecast and Growth Rate (2022-2028)

    • Figure Denmark Finasteride Consumption Forecast and Growth Rate (2022-2028)

    • Figure Finland Finasteride Consumption Forecast and Growth Rate (2022-2028)

    • Figure Norway Finasteride Consumption Forecast and Growth Rate (2022-2028)

    • Figure Sweden Finasteride Consumption Forecast and Growth Rate (2022-2028)

    • Figure Poland Finasteride Consumption Forecast and Growth Rate (2022-2028)

    • Figure Russia Finasteride Consumption Forecast and Growth Rate (2022-2028)

    • Figure Turkey Finasteride Consumption Forecast and Growth Rate (2022-2028)

    • Table APAC Finasteride Consumption Forecast by Country (2022-2028)

    • Figure China Finasteride Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Finasteride Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Finasteride Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Finasteride Consumption Forecast and Growth Rate (2022-2028)

    • Figure Pakistan Finasteride Consumption Forecast and Growth Rate (2022-2028)

    • Figure Bangladesh Finasteride Consumption Forecast and Growth Rate (2022-2028)

    • Figure Indonesia Finasteride Consumption Forecast and Growth Rate (2022-2028)

    • Figure Thailand Finasteride Consumption Forecast and Growth Rate (2022-2028)

    • Figure Singapore Finasteride Consumption Forecast and Growth Rate (2022-2028)

    • Figure Malaysia Finasteride Consumption Forecast and Growth Rate (2022-2028)

    • Figure Philippines Finasteride Consumption Forecast and Growth Rate (2022-2028)

    • Figure Vietnam Finasteride Consumption Forecast and Growth Rate (2022-2028)

    • Table South America Finasteride Consumption Forecast by Country (2022-2028)

    • Figure Brazil Finasteride Consumption Forecast and Growth Rate (2022-2028)

    • Figure Colombia Finasteride Consumption Forecast and Growth Rate (2022-2028)

    • Figure Chile Finasteride Consumption Forecast and Growth Rate (2022-2028)

    • Figure Argentina Finasteride Consumption Forecast and Growth Rate (2022-2028)

    • Figure Venezuela Finasteride Consumption Forecast and Growth Rate (2022-2028)

    • Figure Peru Finasteride Consumption Forecast and Growth Rate (2022-2028)

    • Figure Puerto Rico Finasteride Consumption Forecast and Growth Rate (2022-2028)

    • Figure Ecuador Finasteride Consumption Forecast and Growth Rate (2022-2028)

    • Table GCC Finasteride Consumption Forecast by Country (2022-2028)

    • Figure Bahrain Finasteride Consumption Forecast and Growth Rate (2022-2028)

    • Figure Kuwait Finasteride Consumption Forecast and Growth Rate (2022-2028)

    • Figure Oman Finasteride Consumption Forecast and Growth Rate (2022-2028)

    • Figure Qatar Finasteride Consumption Forecast and Growth Rate (2022-2028)

    • Figure Saudi Arabia Finasteride Consumption Forecast and Growth Rate (2022-2028)

    • Figure United Arab Emirates Finasteride Consumption Forecast and Growth Rate (2022-2028)

    • Table Africa Finasteride Consumption Forecast by Country (2022-2028)

    • Figure Nigeria Finasteride Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Africa Finasteride Consumption Forecast and Growth Rate (2022-2028)

    • Figure Egypt Finasteride Consumption Forecast and Growth Rate (2022-2028)

    • Figure Algeria Finasteride Consumption Forecast and Growth Rate (2022-2028)

    • Table Oceania Finasteride Consumption Forecast by Country (2022-2028)

    • Figure Australia Finasteride Consumption Forecast and Growth Rate (2022-2028)

    • Figure New Zealand Finasteride Consumption Forecast and Growth Rate (2022-2028)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US